Skip to main content

Case Comprehensive Cancer Center

NPR's Morning Edition Features Team's Research on Obesity, Cancer, and GLP1s
Hsin-Ti (Cindy) Lin, MD, and Benjamin Liu, MD, both Residents at MetroHealth, were interviewed by National Public Radio's (NPR) health correspondent, Yuki Noguchi, about their research on the promise of GLP-1 agonists, a class of drugs now being used to treat diabetes and weight loss, for use in…
Parameswaran Passes the Torch to Metheny for New Trial Exploring BAFF CAR T-cell Therapy for Relapsed Myeloma
January 2022 debuted Reshmi Parameswaran's novel B-cell activating factor (BAFF) CAR T product effective at killing multiple B-cell cancers with robust in vitro and in vivo cytotoxicity exerted by these cells against mantle cell lymphoma, multiple myeloma, and acute lymphoblastic leukemia. This…
Spratt Assesses Associations Between the Decipher GC and Risks of Metastasis/BCR after Prostate Biopsy/Radical Prostatectomy in Patients
Daniel Spratt, MD, member of Case CCC's Developmental Therapeutics Program, conducted a retrospective cohort study assessing the associations between the Decipher Genomic Classifier (Decipher GC), a test that improves understanding of the aggressiveness of a patient's prostate cancer, and risks of…
Sossey-Alaoui Co-Authors Article Highlighting the Importance of Cross-Talk Between Cancer Cells and Recipient Cells
Case CCC Molecular Oncology Program member Khalid Sossey-Alaoui, PhD, and Thomas Jefferson University's Lucia Languino, PhD, conducted a collaborative study that appears in a recent Journal of Extracellular Vesicles. The study, Expression of the αVβ3 integrin affects prostate cancer sEV cargo and…
sunscreen-feat
Case Comprehensive Cancer Center, Cleveland Metroparks partner to address high rates of skin cancer in Northeast Ohio
Case Comprehensive Cancer Center (Case CCC) and Cleveland Metroparks have partnered to make it easier for people to prevent skin cancer. Free sunscreen will be available to all visitors at participating Cleveland Metroparks beaches and golf courses. The project, “Be Sun Smart. Protect Your Skin…
Schmit Study Determining CRC Screening Priority Areas Published in American Journal of Public Health
A study with Case CCC's Population and Cancer Prevention Co-Leader Stephanie Schmit, PhD, MPH, as Principal Investigator aims to close the healthcare gap that disproportionately affects Hispanic/Latino (H/L) communities in the U.S. by identifying colorectal cancer screening (CRC) screening…
Study is the Bees Knees—Erm, Nose
Case CCC Population and Cancer Prevention Program member, Mohamed Draz, PhD, provided background information for a study published this week in MDLinx that indicates honey bees can detect certain cancers with nearly 90% accuracy. Draz explains, “Cancer metabolism produces specific compounds that…
Case Comprehensive Cancer Center, Cleveland Metroparks Partner to Address High Rates of Skin Cancer in Northeast Ohio
Case Comprehensive Cancer Center (Case CCC) and Cleveland Metroparks have partnered to make it easier for people to prevent skin cancer. Free sunscreen will be available to all visitors at participating Cleveland Metroparks beaches and golf courses.  The project, "Be Sun Smart. Protect Your Skin…
cancer-cells
Unlocking the mystery of preexisting drug resistance: New study sheds light on cancer evolution
The evolution of resistance to diseases, from infectious illnesses to cancers, poses a formidable challenge. Despite the expectation that resistance-conferring mutations would dwindle in the absence of treatment due to a reduced growth rate, preexisting resistance is pervasive across diseases…
Reda-Riffi
Undergraduate student Reda Riffi selected for prestigious BioMed Amgen Scholars Program at Yale University
Reda Riffi, a first-generation student at Case Western Reserve University, was selected to participate in the BioMed Amgen Scholars Program at Yale University this summer. Riffi is majoring in neuroscience and conducts research at CWRU in the Xiong Lab. The BioMed Amgen Scholars Program is a…